-
1
-
-
67650626749
-
Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses
-
Kunisaki KM, Janoff EN. 2009. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 9:493-504. http://dx.doi.org/10.1016/S1473-3099(09)70175-6.
-
(2009)
Lancet Infect Dis
, vol.9
, pp. 493-504
-
-
Kunisaki, K.M.1
Janoff, E.N.2
-
2
-
-
84886995075
-
Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa, 2009-2011
-
Cohen C, Moyes J, Tempia S, Groom M, Walaza S, Pretorius M, Dawood H, Chhagan M, Haffejee S, Variava E, Kahn K, Tshangela A, von Gottberg A, Wolter N, Cohen AL, Kgokong B, Venter M, Madhi SA. 2013. Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa, 2009-2011. Emerg Infect Dis 19:1766-1774. http://dx.doi.org/10.3201/eid1911.130546.
-
(2013)
Emerg Infect Dis
, vol.19
, pp. 1766-1774
-
-
Cohen, C.1
Moyes, J.2
Tempia, S.3
Groom, M.4
Walaza, S.5
Pretorius, M.6
Dawood, H.7
Chhagan, M.8
Haffejee, S.9
Variava, E.10
Kahn, K.11
Tshangela, A.12
von Gottberg, A.13
Wolter, N.14
Cohen, A.L.15
Kgokong, B.16
Venter, M.17
Madhi, S.A.18
-
3
-
-
0033592341
-
Efficacy of influenza vaccination in HIV-infected persons. A randomized, doubleblind, placebo-controlled trial
-
Tasker SA, Treanor JJ, Paxton WB, Wallace MR. 1999. Efficacy of influenza vaccination in HIV-infected persons. A randomized, doubleblind, placebo-controlled trial. Ann Intern Med 131:430-433.
-
(1999)
Ann Intern Med
, vol.131
, pp. 430-433
-
-
Tasker, S.A.1
Treanor, J.J.2
Paxton, W.B.3
Wallace, M.R.4
-
4
-
-
78649953803
-
Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes
-
Wang TT, Tan GS, Hai R, Pica N, Ngai L, Ekiert DC, Wilson IA, Garcia-Sastre A, Moran TM, Palese P. 2010. Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc Natl Acad SciUSA107:18979-18984. http://dx.doi.org/10.1073/pnas.1013387107.
-
(2010)
Proc Natl Acad SciUSA
, vol.107
, pp. 18979-18984
-
-
Wang, T.T.1
Tan, G.S.2
Hai, R.3
Pica, N.4
Ngai, L.5
Ekiert, D.C.6
Wilson, I.A.7
Garcia-Sastre, A.8
Moran, T.M.9
Palese, P.10
-
5
-
-
84904263611
-
Influenza-specific antibodydependent cellular cytotoxicity: toward a universal influenza vaccine
-
Jegaskanda S, Reading PC, Kent SJ. 2014. Influenza-specific antibodydependent cellular cytotoxicity: toward a universal influenza vaccine. J Immunol 193:469-475. http://dx.doi.org/10.4049/jimmunol.1400432.
-
(2014)
J Immunol
, vol.193
, pp. 469-475
-
-
Jegaskanda, S.1
Reading, P.C.2
Kent, S.J.3
-
6
-
-
0021037896
-
Antibody-dependent cellmediated cytotoxicity against influenza virus-infected cells
-
Hashimoto G, Wright PF, Karzon DT. 1983. Antibody-dependent cellmediated cytotoxicity against influenza virus-infected cells. J Infect Dis 148:785-794. http://dx.doi.org/10.1093/infdis/148.5.785.
-
(1983)
J Infect Dis
, vol.148
, pp. 785-794
-
-
Hashimoto, G.1
Wright, P.F.2
Karzon, D.T.3
-
7
-
-
0018305916
-
Cell cytotoxicity due to specific influenza antibody production in vitro after recent influenza antigen stimulation
-
Greenberg SB, Six HR, Drake S, Couch RB. 1979. Cell cytotoxicity due to specific influenza antibody production in vitro after recent influenza antigen stimulation. Proc Natl Acad SciUSA76:4622-4626. http://dx.doi.org/10.1073/pnas.76.9.4622.
-
(1979)
Proc Natl Acad SciUSA
, vol.76
, pp. 4622-4626
-
-
Greenberg, S.B.1
Six, H.R.2
Drake, S.3
Couch, R.B.4
-
8
-
-
0035877057
-
Fc receptormediated phagocytosis makes a significant contribution to clearance of influenza virus infections
-
Huber VC, Lynch JM, Bucher DJ, Le J, Metzger DW. 2001. Fc receptormediated phagocytosis makes a significant contribution to clearance of influenza virus infections. J Immunol 166:7381-7388. http://dx.doi.org/10.4049/jimmunol.166.12.7381.
-
(2001)
J Immunol
, vol.166
, pp. 7381-7388
-
-
Huber, V.C.1
Lynch, J.M.2
Bucher, D.J.3
Le, J.4
Metzger, D.W.5
-
9
-
-
0030611089
-
A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease
-
Wu J, Edberg JC, Redecha PB, Bansal V, Guyre PM, Coleman K, Salmon JE, Kimberly RP. 1997. A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 100:1059-1070. http://dx.doi.org/10.1172/JCI119616.
-
(1997)
J Clin Invest
, vol.100
, pp. 1059-1070
-
-
Wu, J.1
Edberg, J.C.2
Redecha, P.B.3
Bansal, V.4
Guyre, P.M.5
Coleman, K.6
Salmon, J.E.7
Kimberly, R.P.8
-
10
-
-
84926169101
-
HIV-specific antibody-dependent phagocytosis matures during HIV infection
-
Ana-Sosa-Batiz F, Johnston AP, Liu H, Center RJ, Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Kim JH, Michael NL, Kelleher AD, Stratov I, Kent SJ, Kramski M. 2014. HIV-specific antibody-dependent phagocytosis matures during HIV infection. Immunol Cell Biol 92:679-687. http://dx.doi.org/10.1038/icb.2014.42.
-
(2014)
Immunol Cell Biol
, vol.92
, pp. 679-687
-
-
Ana-Sosa-Batiz, F.1
Johnston, A.P.2
Liu, H.3
Center, R.J.4
Rerks-Ngarm, S.5
Pitisuttithum, P.6
Nitayaphan, S.7
Kaewkungwal, J.8
Kim, J.H.9
Michael, N.L.10
Kelleher, A.D.11
Stratov, I.12
Kent, S.J.13
Kramski, M.14
-
11
-
-
84893797938
-
Broadly neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against influenza virus in vivo
-
DiLillo DJ, Tan GS, Palese P, Ravetch JV. 2014. Broadly neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against influenza virus in vivo. Nat Med 20:143-151. http://dx.doi.org/10.1038/nm.3443.
-
(2014)
Nat Med
, vol.20
, pp. 143-151
-
-
DiLillo, D.J.1
Tan, G.S.2
Palese, P.3
Ravetch, J.V.4
-
12
-
-
84877317499
-
Antibodydependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques
-
Jegaskanda S, Weinfurter JT, Friedrich TC, Kent SJ. 2013. Antibodydependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques. J Virol 87:5512-5522. http://dx.doi.org/10.1128/JVI.03030-12.
-
(2013)
J Virol
, vol.87
, pp. 5512-5522
-
-
Jegaskanda, S.1
Weinfurter, J.T.2
Friedrich, T.C.3
Kent, S.J.4
-
13
-
-
84888051249
-
Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques
-
Jegaskanda S, Amarasena TH, Laurie KL, Tan HX, Butler J, Parsons MS, Alcantara S, Petravic J, Davenport MP, Hurt AC, Reading PC, Kent SJ. 2013. Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques. J Virol 87: 13706-13718. http://dx.doi.org/10.1128/JVI.01666-13.
-
(2013)
J Virol
, vol.87
, pp. 13706-13718
-
-
Jegaskanda, S.1
Amarasena, T.H.2
Laurie, K.L.3
Tan, H.X.4
Butler, J.5
Parsons, M.S.6
Alcantara, S.7
Petravic, J.8
Davenport, M.P.9
Hurt, A.C.10
Reading, P.C.11
Kent, S.J.12
-
14
-
-
84879284427
-
Insights into B cells and HIV-specific B-cell responses in HIV-infected individuals
-
Moir S, Fauci AS. 2013. Insights into B cells and HIV-specific B-cell responses in HIV-infected individuals. Immunol Rev 254:207-224. http://dx.doi.org/10.1111/imr.12067.
-
(2013)
Immunol Rev
, vol.254
, pp. 207-224
-
-
Moir, S.1
Fauci, A.S.2
-
15
-
-
77958170681
-
Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October-December 2009
-
McVernon J, Laurie K, Nolan T, Owen R, Irving D, Capper H, Hyland C, Faddy H, Carolan L, Barr I, Kelso A. 2010. Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October-December 2009. Euro Surveill 15(40):19678. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19678.
-
(2010)
Euro Surveill
, vol.15
, Issue.40
, pp. 19678
-
-
McVernon, J.1
Laurie, K.2
Nolan, T.3
Owen, R.4
Irving, D.5
Capper, H.6
Hyland, C.7
Faddy, H.8
Carolan, L.9
Barr, I.10
Kelso, A.11
-
16
-
-
0028281045
-
Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells
-
Gong JH, Maki G, Klingemann HG. 1994. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia 8:652-658.
-
(1994)
Leukemia
, vol.8
, pp. 652-658
-
-
Gong, J.H.1
Maki, G.2
Klingemann, H.G.3
-
17
-
-
44449090613
-
Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy
-
Binyamin L, Alpaugh RK, Hughes TL, Lutz CT, Campbell KS, Weiner LM. 2008. Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy. J Immunol 180:6392-6401. http://dx.doi.org/10.4049/jimmunol.180.9.6392.
-
(2008)
J Immunol
, vol.180
, pp. 6392-6401
-
-
Binyamin, L.1
Alpaugh, R.K.2
Hughes, T.L.3
Lutz, C.T.4
Campbell, K.S.5
Weiner, L.M.6
-
18
-
-
0028344935
-
Antibody response to influenza, tetanus and pneumococcal vaccines in HIVseropositive individuals in relation to the number of CD4αlymphocytes
-
Kroon FP, van Dissel JT, de Jong JC, van Furth R. 1994. Antibody response to influenza, tetanus and pneumococcal vaccines in HIVseropositive individuals in relation to the number of CD4αlymphocytes. AIDS 8:469-476. http://dx.doi.org/10.1097/00002030-199404000-00008.
-
(1994)
AIDS
, vol.8
, pp. 469-476
-
-
Kroon, F.P.1
van Dissel, J.T.2
de Jong, J.C.3
van Furth, R.4
-
19
-
-
84865531798
-
Responses to pandemic ASO3-adjuvanted A/California/07/09 H1N1 influenza vaccine in human immunodeficiency virus-infected individuals
-
Kelly D, Burt K, Missaghi B, Barrett L, Keynan Y, Fowke K, Grant M. 2012. Responses to pandemic ASO3-adjuvanted A/California/07/09 H1N1 influenza vaccine in human immunodeficiency virus-infected individuals. BMC Immunol 13:49. http://dx.doi.org/10.1186/1471-2172-13-49.
-
(2012)
BMC Immunol
, vol.13
, pp. 49
-
-
Kelly, D.1
Burt, K.2
Missaghi, B.3
Barrett, L.4
Keynan, Y.5
Fowke, K.6
Grant, M.7
-
20
-
-
20244373953
-
Compromised B cell responses to influenza vaccination in HIV-infected individuals
-
Malaspina A, Moir S, Orsega SM, Vasquez J, Miller NJ, Donoghue ET, Kottilil S, Gezmu M, Follmann D, Vodeiko GM, Levandowski RA, Mican JM, Fauci AS. 2005. Compromised B cell responses to influenza vaccination in HIV-infected individuals. J Infect Dis 191:1442-1450. http://dx.doi.org/10.1086/429298.
-
(2005)
J Infect Dis
, vol.191
, pp. 1442-1450
-
-
Malaspina, A.1
Moir, S.2
Orsega, S.M.3
Vasquez, J.4
Miller, N.J.5
Donoghue, E.T.6
Kottilil, S.7
Gezmu, M.8
Follmann, D.9
Vodeiko, G.M.10
Levandowski, R.A.11
Mican, J.M.12
Fauci, A.S.13
-
21
-
-
0028199683
-
Serologic response to standard inactivated influenza vaccine in human immunodeficiency virus-infected children
-
Chadwick EG, Chang G, Decker MD, Yogev R, Dimichele D, Edwards KM. 1994. Serologic response to standard inactivated influenza vaccine in human immunodeficiency virus-infected children. Pediatr Infect Dis J 13:206-211. http://dx.doi.org/10.1097/00006454-199403000-00008.
-
(1994)
Pediatr Infect Dis J
, vol.13
, pp. 206-211
-
-
Chadwick, E.G.1
Chang, G.2
Decker, M.D.3
Yogev, R.4
Dimichele, D.5
Edwards, K.M.6
-
22
-
-
84975137953
-
The impact of vaccination on the breadth and magnitude of the antibody response to influenza A viruses in HIVinfected individuals
-
Kohler I, Kouyos R, Bianchi M, Grube C, Wyrzucki A, Gunthard HF, Hangartner L. 2015. The impact of vaccination on the breadth and magnitude of the antibody response to influenza A viruses in HIVinfected individuals. AIDS 29:1803-1810. http://dx.doi.org/10.1097/QAD.0000000000000772.
-
(2015)
AIDS
, vol.29
, pp. 1803-1810
-
-
Kohler, I.1
Kouyos, R.2
Bianchi, M.3
Grube, C.4
Wyrzucki, A.5
Gunthard, H.F.6
Hangartner, L.7
-
23
-
-
47049113479
-
Humoral and cellular response to influenza vaccine in HIV-infected children with full viroimmunologic response to antiretroviral therapy
-
Vigano A, Zuccotti GV, Pacei M, Erba P, Castelletti E, Giacomet V, Amendola A, Pariani E, Tanzi E, Clerici M. 2008. Humoral and cellular response to influenza vaccine in HIV-infected children with full viroimmunologic response to antiretroviral therapy. J Acquir Immune Defic Syndr 48:289-296. http://dx.doi.org/10.1097/QAI.0b013e3181632cda.
-
(2008)
J Acquir Immune Defic Syndr
, vol.48
, pp. 289-296
-
-
Vigano, A.1
Zuccotti, G.V.2
Pacei, M.3
Erba, P.4
Castelletti, E.5
Giacomet, V.6
Amendola, A.7
Pariani, E.8
Tanzi, E.9
Clerici, M.10
-
24
-
-
0032480989
-
Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy
-
Kroon FP, Rimmelzwaan GF, Roos MT, Osterhaus AD, Hamann D, Miedema F, van Dissel JT. 1998. Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy. AIDS 12:F217-F223. http://dx.doi.org/10.1097/00002030-199817000-00002.
-
(1998)
AIDS
, vol.12
, pp. F217-F223
-
-
Kroon, F.P.1
Rimmelzwaan, G.F.2
Roos, M.T.3
Osterhaus, A.D.4
Hamann, D.5
Miedema, F.6
van Dissel, J.T.7
-
25
-
-
84865423494
-
Cellular and humoral immune responses to pandemic influenza vaccine in healthy and in highly active antiretroviral therapy-treated HIV patients
-
Agrati C, Gioia C, Castilletti C, Lapa D, Berno G, Puro V, Carletti F, Cimini E, Nisii C, Castellino F, Martini F, Capobianchi MR. 2012. Cellular and humoral immune responses to pandemic influenza vaccine in healthy and in highly active antiretroviral therapy-treated HIV patients. AIDS ResHumRetroviruses 28:1606-1616. http://dx.doi.org/10.1089/aid.2011.0371.
-
(2012)
AIDS ResHumRetroviruses
, vol.28
, pp. 1606-1616
-
-
Agrati, C.1
Gioia, C.2
Castilletti, C.3
Lapa, D.4
Berno, G.5
Puro, V.6
Carletti, F.7
Cimini, E.8
Nisii, C.9
Castellino, F.10
Martini, F.11
Capobianchi, M.R.12
-
26
-
-
84873547392
-
Crossreactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies
-
Jegaskanda S, Job ER, Kramski M, Laurie K, Isitman G, de Rose R, Winnall WR, Stratov I, Brooks AG, Reading PC, Kent SJ. 2013. Crossreactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies. J Immunol 190:1837-1848. http://dx.doi.org/10.4049/jimmunol.1201574.
-
(2013)
J Immunol
, vol.190
, pp. 1837-1848
-
-
Jegaskanda, S.1
Job, E.R.2
Kramski, M.3
Laurie, K.4
Isitman, G.5
de Rose, R.6
Winnall, W.R.7
Stratov, I.8
Brooks, A.G.9
Reading, P.C.10
Kent, S.J.11
-
27
-
-
84922324388
-
Cross-reactive influenzaspecific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses
-
Jegaskanda S, Vandenberg K, Laurie KL, Loh L, Kramski M, Winnall WR, Kedzierska K, Rockman S, Kent SJ. 2014. Cross-reactive influenzaspecific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses. J Infect Dis 210:1811-1822. http://dx.doi.org/10.1093/infdis/jiu334.
-
(2014)
J Infect Dis
, vol.210
, pp. 1811-1822
-
-
Jegaskanda, S.1
Vandenberg, K.2
Laurie, K.L.3
Loh, L.4
Kramski, M.5
Winnall, W.R.6
Kedzierska, K.7
Rockman, S.8
Kent, S.J.9
-
28
-
-
84943394845
-
High antibody-dependent cellular cytotoxicity antibody titers to H5N1 and H7N9 avian influenza A viruses in healthy US adults and older children
-
Terajima M, Co MD, Cruz J, Ennis FA. 2015. High antibody-dependent cellular cytotoxicity antibody titers to H5N1 and H7N9 avian influenza A viruses in healthy US adults and older children. J Infect Dis 212:1052-1060. http://dx.doi.org/10.1093/infdis/jiv181.
-
(2015)
J Infect Dis
, vol.212
, pp. 1052-1060
-
-
Terajima, M.1
Co, M.D.2
Cruz, J.3
Ennis, F.A.4
-
29
-
-
84899105650
-
Polyfunctional Fceffector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines
-
Chung AW, Ghebremichael M, Robinson H, Brown E, Choi I, Lane S, Dugast AS, Schoen MK, Rolland M, Suscovich TJ, Mahan AE, Liao L, Streeck H, Andrews C, Rerks-Ngarm S, Nitayaphan S, de Souza MS, Kaewkungwal J, Pitisuttithum P, Francis D, Michael NL, Kim JH, Bailey-Kellogg C, Ackerman ME, Alter G. 2014. Polyfunctional Fceffector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines. Sci Transl Med 6(228):228ra38. http://dx.doi.org/10.1126/scitranslmed.3007736.
-
(2014)
Sci Transl Med
, vol.6
, Issue.228
-
-
Chung, A.W.1
Ghebremichael, M.2
Robinson, H.3
Brown, E.4
Choi, I.5
Lane, S.6
Dugast, A.S.7
Schoen, M.K.8
Rolland, M.9
Suscovich, T.J.10
Mahan, A.E.11
Liao, L.12
Streeck, H.13
Andrews, C.14
Rerks-Ngarm, S.15
Nitayaphan, S.16
de Souza, M.S.17
Kaewkungwal, J.18
Pitisuttithum, P.19
Francis, D.20
Michael, N.L.21
Kim, J.H.22
Bailey-Kellogg, C.23
Ackerman, M.E.24
Alter, G.25
more..
-
30
-
-
0141660742
-
Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59-adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy
-
Iorio AM, Francisci D, Camilloni B, Stagni G, De Martino M, Toneatto D, Bugarini R, Neri M, Podda A. 2003. Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59-adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy. Vaccine 21: 3629-3637. http://dx.doi.org/10.1016/S0264-410X(03)00408-0.
-
(2003)
Vaccine
, vol.21
, pp. 3629-3637
-
-
Iorio, A.M.1
Francisci, D.2
Camilloni, B.3
Stagni, G.4
De Martino, M.5
Toneatto, D.6
Bugarini, R.7
Neri, M.8
Podda, A.9
-
31
-
-
84921062118
-
Hemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infection
-
Fox A, Mai le Q, Thanh le T, Wolbers M, Le Khanh Hang N, Thai PQ, Thi Thu Yen N, Minh Hoale N, Bryant JE, Duong TN, Thoang DD, Barr IG, Wertheim H, Farrar J, Hien NT, Horby P. 2015. Hemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infection. J Infect 70:187-196. http://dx.doi.org/10.1016/j.jinf.2014.09.003.
-
(2015)
J Infect
, vol.70
, pp. 187-196
-
-
Fox, A.1
Mai le, Q.2
Thanh le, T.3
Wolbers, M.4
Le Khanh Hang, N.5
Thai, P.Q.6
Thi Thu Yen, N.7
Minh Hoale, N.8
Bryant, J.E.9
Duong, T.N.10
Thoang, D.D.11
Barr, I.G.12
Wertheim, H.13
Farrar, J.14
Hien, N.T.15
Horby, P.16
-
32
-
-
77951011752
-
Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model
-
Coudeville L, Bailleux F, Riche B, Megas F, Andre P, Ecochard R. 2010. Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model. BMC Med Res Methodol 10:18. http://dx.doi.org/10.1186/1471-2288-10-18.
-
(2010)
BMC Med Res Methodol
, vol.10
, pp. 18
-
-
Coudeville, L.1
Bailleux, F.2
Riche, B.3
Megas, F.4
Andre, P.5
Ecochard, R.6
-
33
-
-
77953643545
-
Dysfunctional B-cell responses during HIV-1 infection: implication for influenza vaccination and highly active antiretroviral therapy
-
Cagigi A, Nilsson A, Pensieroso S, Chiodi F. 2010. Dysfunctional B-cell responses during HIV-1 infection: implication for influenza vaccination and highly active antiretroviral therapy. Lancet Infect Dis 10:499-503. http://dx.doi.org/10.1016/S1473-3099(10)70117-1.
-
(2010)
Lancet Infect Dis
, vol.10
, pp. 499-503
-
-
Cagigi, A.1
Nilsson, A.2
Pensieroso, S.3
Chiodi, F.4
-
34
-
-
84864555009
-
Impaired peripheral blood T-follicular helper cell function in HIV-infected nonresponders to the 2009 H1N1/09 vaccine
-
Pallikkuth S, Parmigiani A, Silva SY, George VK, Fischl M, Pahwa R, Pahwa S. 2012. Impaired peripheral blood T-follicular helper cell function in HIV-infected nonresponders to the 2009 H1N1/09 vaccine. Blood 120:985-993. http://dx.doi.org/10.1182/blood-2011-12-396648.
-
(2012)
Blood
, vol.120
, pp. 985-993
-
-
Pallikkuth, S.1
Parmigiani, A.2
Silva, S.Y.3
George, V.K.4
Fischl, M.5
Pahwa, R.6
Pahwa, S.7
-
35
-
-
84905561206
-
Seroprotection of HIV-infected subjects after influenza A(H1N1) vaccination is directly associated with baseline frequency of naive T cells
-
Ramirez LA, Daniel A, Frank I, Tebas P, Boyer JD. 2014. Seroprotection of HIV-infected subjects after influenza A(H1N1) vaccination is directly associated with baseline frequency of naive T cells. J Infect Dis 210:646-650. http://dx.doi.org/10.1093/infdis/jiu132.
-
(2014)
J Infect Dis
, vol.210
, pp. 646-650
-
-
Ramirez, L.A.1
Daniel, A.2
Frank, I.3
Tebas, P.4
Boyer, J.D.5
-
36
-
-
84863116131
-
Seasonal H1N1 influenza virus infection induces cross-protective pandemic H1N1 virus immunity through a CD8-independent, B cell-dependent mechanism
-
Fang Y, Banner D, Kelvin AA, Huang SS, Paige CJ, Corfe SA, Kane KP, Bleackley RC, Rowe T, Leon AJ, Kelvin DJ. 2012. Seasonal H1N1 influenza virus infection induces cross-protective pandemic H1N1 virus immunity through a CD8-independent, B cell-dependent mechanism. J Virol 86:2229-2238. http://dx.doi.org/10.1128/JVI.05540-11.
-
(2012)
J Virol
, vol.86
, pp. 2229-2238
-
-
Fang, Y.1
Banner, D.2
Kelvin, A.A.3
Huang, S.S.4
Paige, C.J.5
Corfe, S.A.6
Kane, K.P.7
Bleackley, R.C.8
Rowe, T.9
Leon, A.J.10
Kelvin, D.J.11
-
37
-
-
84887266053
-
Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1
-
Jegaskanda S, Laurie KL, Amarasena TH, Winnall WR, Kramski M, De Rose R, Barr IG, Brooks AG, Reading PC, Kent SJ. 2013. Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1. J Infect Dis 208:1051-1061. http://dx.doi.org/10.1093/infdis/jit294.
-
(2013)
J Infect Dis
, vol.208
, pp. 1051-1061
-
-
Jegaskanda, S.1
Laurie, K.L.2
Amarasena, T.H.3
Winnall, W.R.4
Kramski, M.5
De Rose, R.6
Barr, I.G.7
Brooks, A.G.8
Reading, P.C.9
Kent, S.J.10
-
38
-
-
84891121586
-
Anti-HIV antibody-dependent activation of NK cells impairs NKp46 expression
-
Parsons MS, Tang CC, Jegaskanda S, Center RJ, Brooks AG, Stratov I, Kent SJ. 2014. Anti-HIV antibody-dependent activation of NK cells impairs NKp46 expression. J Immunol 192:308-315. http://dx.doi.org/10.4049/jimmunol.1301247.
-
(2014)
J Immunol
, vol.192
, pp. 308-315
-
-
Parsons, M.S.1
Tang, C.C.2
Jegaskanda, S.3
Center, R.J.4
Brooks, A.G.5
Stratov, I.6
Kent, S.J.7
-
39
-
-
84864118206
-
Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activation
-
Lichtfuss GF, Cheng WJ, Farsakoglu Y, Paukovics G, Rajasuriar R, Velayudham P, Kramski M, Hearps AC, Cameron PU, Lewin SR, Crowe SM, Jaworowski A. 2012. Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activation. J Immunol 189:1491-1499. http://dx.doi.org/10.4049/jimmunol.1200458.
-
(2012)
J Immunol
, vol.189
, pp. 1491-1499
-
-
Lichtfuss, G.F.1
Cheng, W.J.2
Farsakoglu, Y.3
Paukovics, G.4
Rajasuriar, R.5
Velayudham, P.6
Kramski, M.7
Hearps, A.C.8
Cameron, P.U.9
Lewin, S.R.10
Crowe, S.M.11
Jaworowski, A.12
-
40
-
-
0141650530
-
The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44)
-
De Maria A, Fogli M, Costa P, Murdaca G, Puppo F, Mavilio D, Moretta A, Moretta L. 2003. The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur J Immunol 33:2410-2418. http://dx.doi.org/10.1002/eji.200324141.
-
(2003)
Eur J Immunol
, vol.33
, pp. 2410-2418
-
-
De Maria, A.1
Fogli, M.2
Costa, P.3
Murdaca, G.4
Puppo, F.5
Mavilio, D.6
Moretta, A.7
Moretta, L.8
-
41
-
-
77949694744
-
DecreasedNKCell FcRgamma in HIV-1 infected individuals receiving combination antiretroviral therapy: a cross sectional study
-
Leeansyah E, Zhou J, Paukovics G, Lewin SR, Crowe SM, Jaworowski A. 2010. DecreasedNKCell FcRgamma in HIV-1 infected individuals receiving combination antiretroviral therapy: a cross sectional study. PLoS One 5:e9643. http://dx.doi.org/10.1371/journal.pone.0009643.
-
(2010)
PLoS One
, vol.5
-
-
Leeansyah, E.1
Zhou, J.2
Paukovics, G.3
Lewin, S.R.4
Crowe, S.M.5
Jaworowski, A.6
-
42
-
-
84936803233
-
H5N1 vaccine-elicited memory B cells are genetically constrained by the IGHV locus in the recognition of a neutralizing epitope in the hemagglutinin stem
-
Wheatley AK, Whittle JR, Lingwood D, Kanekiyo M, Yassine HM, Ma SS, Narpala SR, Prabhakaran MS, Matus-Nicodemos RA, Bailer RT, Nabel GJ, Graham BS, Ledgerwood JE, Koup RA, McDermott AB. 2015. H5N1 vaccine-elicited memory B cells are genetically constrained by the IGHV locus in the recognition of a neutralizing epitope in the hemagglutinin stem. J Immunol 195:602-610. http://dx.doi.org/10.4049/jimmunol.1402835.
-
(2015)
J Immunol
, vol.195
, pp. 602-610
-
-
Wheatley, A.K.1
Whittle, J.R.2
Lingwood, D.3
Kanekiyo, M.4
Yassine, H.M.5
Ma, S.S.6
Narpala, S.R.7
Prabhakaran, M.S.8
Matus-Nicodemos, R.A.9
Bailer, R.T.10
Nabel, G.J.11
Graham, B.S.12
Ledgerwood, J.E.13
Koup, R.A.14
McDermott, A.B.15
-
43
-
-
84971420974
-
Influenzaspecific antibody-dependent phagocytosis
-
in press
-
Ana-Sosa-Batiz F, Vanderven H, Jegaskanda S, Johnston APR, Rockman S, Laurie K, Barr I, Reading P, Lichtfuss M, Kent SJ. Influenzaspecific antibody-dependent phagocytosis. Plos One, in press.
-
Plos One
-
-
Ana-Sosa-Batiz, F.1
Vanderven, H.2
Jegaskanda, S.3
Johnston, A.P.R.4
Rockman, S.5
Laurie, K.6
Barr, I.7
Reading, P.8
Lichtfuss, M.9
Kent, S.J.10
|